Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases
Romina Fiorotto(Yale University), Mario Strazzabosco(Smilow Cancer Hospital), Luca Fabris(University of Padua), Carlo Spirlı̀(Cancer Research Center), Valeria Mariotti(University of Padua), Mariangela Amenduni(Yale University)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
September 5, 2018
Cited by 61
Related Papers
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
|Hepatology|2018|340
Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
|Hepatology|2020|302
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
|Journal of Hepatology|2018|187